Neoadjuvant nivolumab for patients with non-metastatic high risk kidney cancer
A recent phase 1 trial showed that treatment with nivolumab [...]
A recent phase 1 trial showed that treatment with nivolumab [...]
In this video interview, Dr Eric Jonasch from MD Anderson [...]
In this study carried out at a single hospital 217 [...]
In a study presented during the 2020 American Society of [...]
A recent post hoc analysis of the results from the [...]
Immune checkpoint inhibitors can cause a number of immune-related adverse [...]
In this video interview, Brenda Martone discusses the clinical nurse [...]
Dr Mehmet Asim Bilen of Emory University School of Medicine [...]
Results from this phase III trial of atezolizumab plus bevacizumab [...]
Results from a first-in-human phase 1 study of savolitinib in [...]